» Articles » PMID: 25969835

Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 May 14
PMID 25969835
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Our aim was to search for proteome changes in peripheral blood mononuclear cells (PBMCs) of MDS patients with refractory cytopenia with multilineage dysplasia. PBMCs were isolated from a total of 12 blood samples using a Histopaque-1077 solution. The proteins were fractioned, separated by 2D SDS-PAGE (pI 4-7), and double-stained. The proteomes were compared and statistically processed with Progenesis SameSpots; then proteins were identified by nano-LC-MS/MS. Protein functional association and expression profiles were analyzed using the EnrichNet application and Progenesis SameSpots hierarchical clustering software, respectively. By comparing the cytosolic, membrane, and nuclear fractions of the two groups, 178 significantly (P < 0.05, ANOVA) differing spots were found, corresponding to 139 unique proteins. Data mining of the Reactome and KEGG databases using EnrichNet highlighted the possible involvement of the identified protein alterations in apoptosis, proteasome protein degradation, heat shock protein action, and signal transduction. Western blot analysis revealed underexpression of vinculin and advanced fragmentation of fermitin-3 in MDS patients. To the best of our knowledge, this is the first time that proteome changes have been identified in the mononuclear cells of MDS patients. Vinculin and fermitin-3, the proteins involved in cell adhesion and integrin signaling, have been shown to be dysregulated in MDS.

Citing Articles

Global Proteomics Analysis of Bone Marrow: Establishing Talin-1 and Centrosomal Protein of 55 kDa as Potential Molecular Signatures for Myelodysplastic Syndromes.

Moura A, Bezerra M, Martins A, Borges D, Oliveira R, Oliveira R Front Oncol. 2022; 12:833068.

PMID: 35814389 PMC: 9257025. DOI: 10.3389/fonc.2022.833068.


Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.

Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman S Leuk Lymphoma. 2020; 62(1):229-233.

PMID: 32924688 PMC: 7939047. DOI: 10.1080/10428194.2020.1817446.

References
1.
Vardiman J, Lee Harris N, Brunning R . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002; 100(7):2292-302. DOI: 10.1182/blood-2002-04-1199. View

2.
DeMartino G, Gillette T . Proteasomes: machines for all reasons. Cell. 2007; 129(4):659-62. DOI: 10.1016/j.cell.2007.05.007. View

3.
Takayama S, Reed J, Homma S . Heat-shock proteins as regulators of apoptosis. Oncogene. 2003; 22(56):9041-7. DOI: 10.1038/sj.onc.1207114. View

4.
Nardo G, Pozzi S, Mantovani S, Garbelli S, Marinou K, Basso M . Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS. Antioxid Redox Signal. 2009; 11(7):1559-67. DOI: 10.1089/ars.2009.2548. View

5.
Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View